Showing results (191-200 of 474) with videos related to
Sort By:
Pageof 48
BMC Cancer|April 7, 2018
Sorafenib versus Transarterial chemoembolization for advanced-stage hepatocellular carcinoma: a cost-effectiveness analysisShuling Chen, Zhenwei Peng, Mengchao Wei, et al.Hepatology (Baltimore, Md.)|June 14, 2022
Methyltransferase 1 is required for nonhomologous end-joining repair and renders hepatocellular carcinoma resistant to radiotherapyJunbin Liao, Yang Yi, Xin Yue, et al.Carcinogenesis|July 11, 2020
Cripto-1 promotes tumor invasion and predicts poor outcomes in hepatocellular carcinomaTao Huang, Yi-Zhan Guo, Xiao Yue, et al.Journal of Gastroenterology and Hepatology|April 5, 2020
Hepatic resection versus transarterial chemoembolization in infiltrative hepatocellular carcinoma: A multicenter studyYuanqi Wang, Jingxian Shen, Shiting Feng, et al.Journal of Immunology (Baltimore, Md. : 1950)|June 29, 2010
Tumor-activated monocytes promote expansion of IL-17-producing CD8+ T cells in hepatocellular carcinoma patientsDong-Ming Kuang, Chen Peng, Qiyi Zhao, et al.Journal of Environmental Sciences (China)|August 8, 2013
Biogeochemical reductive release of soil embedded arsenate around a crater area (Guandu) in northern Taiwan using X-ray absorption near-edge spectroscopyKai-Ying Chiang, Tsan-Yao Chen, Chih-Hao Lee, et al.Hepatology (Baltimore, Md.)|December 11, 2012
Monocyte/macrophage-elicited natural killer cell dysfunction in hepatocellular carcinoma is mediated by CD48/2B4 interactionsYan Wu, Dong-Ming Kuang, Wei-Dong Pan, et al.Nan Fang Yi Ke Da Xue Xue Bao = Journal of Southern Medical University|November 9, 2015
[Low expression of SLC22A1 is associated with a poor prognosis of hepatocellular carcinoma: analysis of 303 patients]Shu-Tong Wang, Shun-Li Shen, Yun-Peng Hua, et al.Frontiers in Medicine|September 28, 2020
Anti-PD-1 Immunotherapy and Radiotherapy for Stage IV Intrahepatic Cholangiocarcinoma: A Case ReportZe-Long Liu, Xin Liu, Hong Peng, et al.International Journal of Hyperthermia : the Official Journal of European Society for Hyperthermic Oncology, North American Hyperthermia Group|January 4, 2017
Percutaneous thermal ablation for the treatment of colorectal liver metastases and hepatocellular carcinoma: a comparison of local therapeutic efficacyMing Liu, Guang-Liang Huang, Ming Xu, et al.Pageof 48